CI
ARRY

Cowen Inc’s Array Biopharma Inc ARRY Stock Holding History

Cowen Inc’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$10.1M Buy
+217,408
New +$6.1M 0.73% 28
2017
Q3 		– Sell
-44,000
Closed -$368K – 358
2017
Q2 		$368K Buy
44,000
+1,400
+3% +$11.4K 0.02% 236
2017
Q1 		$381K Buy
+42,600
New +$453K 0.02% 182
2015
Q4 		– Sell
-53,500
Closed -$244K – 357
2015
Q3 		$244K Buy
+53,500
New +$317K 0.01% 203

Other funds holding ARRY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Cowen Inc's ARRY Position: Q2 2019 in Review

Cowen Inc opened a new position in Array Biopharma Inc (ARRY) in Q2 2019: 217,408 shares worth $10.1M. The stake represents 0.73% of the portfolio and ranks #28 among its holdings. This is a return to the name: Cowen Inc previously reported a position in ARRY as recently as Q2 2017.

Cowen Inc first reported a position in ARRY in Q3 2015 and has held it in 4 quarters since. 319 funds tracked by Wall St. Rank hold ARRY as of Q2 2019.

  • Cowen Inc held 217,408 shares of Array Biopharma Inc worth $10.1M as of Q2 2019.
  • Array Biopharma Inc was a new Cowen Inc position in Q2 2019.
  • Array Biopharma Inc made up 0.73% of Cowen Inc's portfolio in Q2 2019, its #28 holding.
  • Cowen Inc first reported a position in Array Biopharma Inc in Q3 2015 and has held it in 4 quarters since.
  • 319 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.